Research Topics
| Gregory J DehmerSummaryAffiliation: Scott and White Memorial Hospital Country: USA Publications
| Collaborators
|
Detail Information
Publications
Frequency of percutaneous coronary interventions at facilities without on-site cardiac surgical backup--a report from the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR)Gregory J Dehmer
Texas A and M University College of Medicine and Cardiology Division, Scott and White Clinic, Temple, Texas, USA
Am J Cardiol 99:329-32. 2007..In conclusion, the significant increase in elective PCIs performed at facilities without on-site surgical backup occurred despite national guidelines that state elective PCI should not be done in centers without on-site cardiac surgery...- Drug-eluting coronary artery stentsGregory J Dehmer
Scott and White Healthcare, 2401 South 31 St, Temple, TX 76508, USA
Am Fam Physician 80:1245-51. 2009..Elective surgery following stent placement should be delayed until the recommended course of dual antiplatelet therapy has been completed... - Percutaneous coronary intervention without onsite surgical backupGregory J Dehmer
Texas A and M University College of Medicine, Cardiology Division, Scott and White Clinic, 2401 South 31st Street, Temple, TX 76508, USA
Curr Cardiol Rep 10:407-14. 2008..Additional studies are currently under way to evaluate PCI's safety and effectiveness in this setting... - SCAI: Going globalGregory J Dehmer
Texas A and M School of Medicine, Cardiology Division, Scott and White Clinic, Temple, Texas 76508, USA
Catheter Cardiovasc Interv 69:768-72. 2007 - Passing the torch: challenges aheadGregory J Dehmer
Texas A and M School of Medicine, Cardiology Division, Scott and White Clinic, Society for Cardiovascular Angiography and Interventions, Temple, Texas, USA
Catheter Cardiovasc Interv 69:928-30. 2007 - The current status and future direction of percutaneous coronary intervention without on-site surgical backup: an expert consensus document from the Society for Cardiovascular Angiography and InterventionsGregory J Dehmer
Cardiology Division, Texas A and M School of Medicine, Scott and White Clinic, 2401 South 31st Street, Temple, TX 76508, USA
Catheter Cardiovasc Interv 69:471-8. 2007 - Temporary coronary guidewire pacing during percutaneous coronary interventionTimothy A Mixon
Department of Medicine, Scott and White Hospital and Clinic, Temple, Texas 76508, USA
Catheter Cardiovasc Interv 61:494-500; discussion 502-3. 2004..Temporary guidewire pacing is easily performed and should be considered as an alternative to the separate placement of a temporary transvenous pacemaker... - Assessment of anticoagulation using activated clotting times in patients receiving intravenous enoxaparin during percutaneous coronary interventionMark Lawrence
Department of Medicine, Division of Cardiology, Scott and White Memorial Hospital and Clinic, Temple, Texas 76508, USA
Catheter Cardiovasc Interv 61:52-5. 2004..Intravenous enoxaparin at clinically relevant doses with and without eptifibatide increases ACT levels at 5 min in patients undergoing PCI. These data suggest the ACT may be useful in the assessment of anticoagulation by enoxaparin... 
Retrospective description and analysis of consecutive catheterization laboratory ST-segment elevation myocardial infarction activations with proposal, rationale, and use of a new classification schemeTimothy A Mixon
Division of Cardiology, Scott and White Healthcare, Temple, TX, USA
Circ Cardiovasc Qual Outcomes 5:62-9. 2012..This process is accelerated with prehospital electrocardiography and notification. False activations of the CCL occur at an unknown rate and have been poorly described...- PCI without on-site surgical backupGregory J Dehmer
Texas A and M School of Medicine, and Cardiology Division, Scott and White Clinic, 2401 South 31st Street, Temple, TX 76508, USA
Catheter Cardiovasc Interv 69:618-22. 2007 - The Cath Lab Crew: your second familyGregory J Dehmer
Texas A and M School of Medicine, Cardiology Division, Scott and White Clinic, Texas, USA
Catheter Cardiovasc Interv 68:815-8. 2006 - Guidewire pacing safely and effectively treats bradyarrhythmias induced by rheolytic thrombectomy and precludes the need for transvenous pacing: the Scott & White experienceTimothy A Mixon
Texas A and M Health Science Center, Scott and White Clinic, Division of Cardiology, 2401 S 31st Street, Temple, TX 76504, USA
J Invasive Cardiol 20:5A-8A. 2008.... - A contemporary view of diagnostic cardiac catheterization and percutaneous coronary intervention in the United States: a report from the CathPCI Registry of the National Cardiovascular Data Registry, 2010 through June 2011Gregory J Dehmer
Texas A and M Health Science Center College of Medicine, Temple, TX, USA
J Am Coll Cardiol 60:2017-31. 2012..This study sought to provide a report to the public of data from the CathPCI Registry of the National Cardiovascular Data Registry... - Enhanced external counterpulsation is a regenerative therapyCoty W Jewell
Department of Medicine, Cardiology Division, University Health Science Center College of Medicine and the Scott and White Clinic, Temple, Texas 76513, USA
Front Biosci (Elite Ed) 2:111-21. 2010.... - Hospital disposition and long-term follow-up of patients aged >/=80 years undergoing coronary artery revascularizationJuan J Garza
Division of Cardiology, Department of Medicine, Scott and White Memorial Hospital and Clinic, Temple, Texas 76205, USA
Am J Cardiol 92:590-2. 2003..It is important that this information become part of the discussion with patients and their families so realistic expectations can be developed... - Occupational hazards for interventional cardiologistsGregory J Dehmer
Texas A and M School of Medicine, Cardiology Division, Scott and White Clinic, Temple, TX 76508, USA
Catheter Cardiovasc Interv 68:974-6. 2006 - Bringing measurement and management science to the cath laboratory: the National Cardiovascular Data Registry (ACC-NCDR) and the Cardiac Catheterization Laboratory Continuous Quality Improvement Toolkit (ACC-CathKIT)Gregory J Dehmer
Cardiology Division, Scott and White Clinic, Temple, TX, USA
J Cardiovasc Manag 15:20-6. 2004..The development and usefulness of these products is described in this paper... - Urinary levels of matrix metalloproteinase 9 and 2 and tissue inhibitor of matrix metalloproteinase in patients with coronary artery diseasePatrick J Fitzsimmons
Department of Medicine, Cardiology Division, Texas A and M University College of Medicine and Scott and White Memorial Hospital, Temple, TX 76508, USA
Atherosclerosis 194:196-203. 2007..To evaluate the feasibility of an assay for urinary levels of matrix metalloproteinases (MMPs) and the potential usefulness of urinary MMPs as a marker of coronary atherosclerosis or acute coronary syndromes (ACS)... - Pay for quality--what every interventional cardiologist needs to know: part IIGregory J Dehmer
Professor of Medicine Texas A and M School of Medicine Director, Cardiology Division Scott and White Clinic Temple, Texas President Society for Cardiovascular Angiography and Interventions, Temple, Texas 76508, USA
Catheter Cardiovasc Interv 68:338-41. 2006 - Relation of atmospheric pressure changes and the occurrences of acute myocardial infarction and strokePhilip D Houck
Department of Medicine, Division of Cardiology, The Scott and White Hospital and Clinic, Temple, Texas, USA
Am J Cardiol 96:45-51. 2005..No relation between stroke and atmospheric pressure was demonstrated. In conclusion, we conclude that rapid decreases in barometric pressure are associated with the occurrence of AMI but not of stroke... - Effectiveness and safety of manual hemostasis facilitated by the SyvekPatch with one hour of bedrest after coronary angiography using six-French cathetersBruce L Palmer
Department of Medicine (Division of Cardiology, Scott and White Hospital and Clinic, Temple, Texas 76508, USA
Am J Cardiol 93:96-7. 2004..The findings suggest that the 1-hour bedrest protocol using the SyvekPatch is safe and effective in low-risk patients... - Patient care before and after percutaneous coronary artery interventionsTimothy A Mixon
Department of Medicine, Scott and White Memorial Hospital and Clinic, Temple, Texas 76508, USA
Am J Med 115:642-51. 2003..It is important for the specialist in internal medicine to have a firm working knowledge of the various aspects of patient care before and after these procedures because their role in the management of these patients is increasing... - Unfractionated heparin reduces the anti-platelet effects of abciximab but not eptifibatide during PCIEfthymios N Deliargyris
Wake Forest University School of Medicine, Winston-Salem, NC 27157-1045, USA
Clin Appl Thromb Hemost 12:458-64. 2006..5% [94-100] vs. 95% [93-100] [ADP]; 89.5% [84-95] vs. 82% [77-93] [TRAP], p=ns for both). Eptifibatide achieved superior platelet inhibition before but especially after UFH compared with abciximab... - Late stent thrombosis: considerations and practical advice for the use of drug-eluting stents: a report from the Society for Cardiovascular Angiography and Interventions Drug-eluting Stent Task ForceJohn McB Hodgson
St. Joseph's Hospital and Medical Center, 350 West Thomas Road, Phoenix, AZ 85013, USA
Catheter Cardiovasc Interv 69:327-33. 2007 - Coronary intervention at hospitals without on-site cardiac surgery: are we pushing the envelope too far?Gregory J Dehmer
J Am Coll Cardiol 43:343-5. 2004 - Relation of serum levels of mast cell tryptase of left ventricular systolic function, left ventricular volume or congestive heart failureBharathi Upadhya
Cardiology Section, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA
J Card Fail 10:31-5. 2004..In contrast, the presence of angiographically significant CAD is associated with elevated systemic tryptase levels... - Drive-through angioplasty: is it safe or necessary?Timothy A Mixon
Circulation 114:2578-80. 2006 - Simultaneous testing of the heparin effect on the soluble phase and platelet component of hemostasisLaura G Melton
Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Am J Med Sci 326:345-52. 2003..These findings probably reflect the variable effect of heparin on platelet function and may explain the poor heparin effect or, alternatively, the excessive bleeding after heparin administration that occurs in some patients... - Premature discontinuation of antiplatelet therapy in patients with drug-eluting coronary stentsRussell K McAllister
Am J Health Syst Pharm 63:2308-10. 2006 - Mast cell tryptase: a new biomarker in patients with stable coronary artery diseaseEfthymios N Deliargyris
Cardiology Section, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1045, USA
Atherosclerosis 178:381-6. 2005..Tryptase measurements may emerge as a novel way of identifying asymptomatic patients with CAD, and represent a new biomarker of therapeutic efficacy in patients with CAD...